BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28800317)

  • 1. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
    Li HY; Jin N; Han YP; Jin XF
    Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
    Qu T; Li YP; Li XH; Chen Y
    Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
    Zhou W; Ma CX; Xing YZ; Yan ZY
    Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes and pathways in pelvic organ prolapse based on gene expression profiling by bioinformatics analysis.
    Zhou Q; Hong L; Wang J
    Arch Gynecol Obstet; 2018 May; 297(5):1323-1332. PubMed ID: 29546564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis.
    Luo S; Cao N; Tang Y; Gu W
    PLoS One; 2017; 12(6):e0178549. PubMed ID: 28594854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
    Zhang H; Liu J; Fu X; Yang A
    Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
    Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
    Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
    Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.